Financhill
Back

Vaxcyte Stock Predictions

Vaxcyte Stock Forecast

  • Over the next 52 weeks, Vaxcyte has on average historically risen by 46.4% based on the past 4 years of stock performance.
  • Vaxcyte has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Vaxcyte Stock Undervalued?
    The current Vaxcyte [PCVX] share price is $116.75. The Score for PCVX is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
  • PCVX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Vaxcyte Stock Go Up Next Year?

  • Over the next 52 weeks, Vaxcyte has on average historically risen by 46.4% based on the past 4 years of stock performance.

Vaxcyte Stock Rating

Buy
74
Vaxcyte (PCVX) is a Buy

Is Vaxcyte overpriced?

  • Vaxcyte has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Vaxcyte Stock Price History

Is PCVX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PCVX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vaxcyte.com

52-Week Data

52-Week High:
119.50
52-Week Low:
44.20

Prediction Charts

Market Cap:
13.03B
Price in USD:
116.75
Volume:
917.42K
Beta:
0.99

Technical Analysis

SMA50:
87.04
SMA100:
78.94
SMA200:
72.42
52-Wk Change:
125.73%

Stock Predictions

  • Is Vaxcyte stock public?
    Yes, Vaxcyte is a publicly traded company.
  • What is the Vaxcyte stock quote today?
    The Vaxcyte stock price is 116.75 USD today.
  • How to buy Vaxcyte stock online?
    You can buy Vaxcyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-28 78.57 78.43 78.69 77.21
Aug-29 79.14 79.28 80.14 78.22
Aug-30 79.58 80.66 80.81 78.36
Sep-3 107.67 110.15 119.27 107.62
Sep-4 113.05 109.15 118.26 108.01
Sep-5 113.28 112.10 113.64 109.73
Sep-6 111.51 111.51 115.44 111.21
Sep-9 112.19 115.26 116.40 111.18
Sep-10 116.50 116.23 119.50 113.77
Sep-11 115.35 113.55 117.38 113.13
Sep-12 113.92 114.15 115.61 112.55
Sep-13 114.80 116.00 117.39 113.58
Sep-16 115.90 114.24 117.00 113.92
Sep-17 113.93 116.75 117.97 113.56

Vaxcyte Earnings

Vaxcyte Earnings Report: Per Share Vaxcyte Earnings Q1 Q2 Q3 and Q4 last year and next year.

Vaxcyte Forecast Revenue Growth

Vaxcyte Stock Analysis: Historical quarterly revenues per share for Vaxcyte and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.84 per share, and a decrease next year of $0.33 per share.

* Vaxcyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.